S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7169 +0.24%
PRE-MKT · 05:20 ET
Market ClerkRecap
Wed Nov 4 · pre-market3 signals on Nov 3175 insider buys this week · $365.2MCIRO short report next: Nov 15The week ahead

KLRS

Kalaris Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
2.05
+0.05 +2.50%
USD · close Nov 3

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

What KLRS had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from KLRS on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch KLRS. Know when insiders buy.
One email the day a filing lands. Free.